(5Z,8R,9R,11S,12S,13E,15R)-11,15-bis-(tert-butyldimethylsilyloxy)-9-oxoprosta-5,13-dienoic acid (303015-41-0)
Identification |
Properties |
Safety Data |
|
|
Other Product
- (5Z,11alpha,13E,15R)-15-(Acetyloxy)-11,16,16-tri- methyl-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E,15R,16R)-16-fluoro-15-hydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E,15S)-15-Hydroxy-9-oxoprosta-5,8(12),13-trien-1-oic acid methyl ester
- (5Z,13E,15S)-11α,15-Dihydroxy-11-methyl-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E)-9α-[(tert-butyldimethylsilyl)oxy]-11-oxo-15-[(tert-butyldiphenylsilyl)oxy]prosta-5,13-dienoic acid
- (5Z,8ξ,13E,15R)-9,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E,15S)-15-hydroxy-15-methyl-11-oxoprosta-5,9,13-trien-1-oic acid
- (5Z,13E,8R,11R,12S,15S)-11,15-Bis(tert-butyldimethylsiloxy)-9-(anti-oximino)-8-(phenylsulfonyl)-5,13-prostadienoic acid
- (5Z,13E,8R,9S,11R,12S,15S)-11,15-Bis(tert-butyldimethylsiloxy)-9-(methylamino)-8-(phenylsulfonyl)-5,13-prostadienoic acid
- (5Z,9α,13E)-9-Hydroxy-11-methylene-15-oxoprosta-5,13-dien-1-oic a cid
- (5Z,13E,15S)-15-Hydroxy-15-methyl-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E)-15-hydroxy-15-methyl-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E,15S)-9α,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic acid 1,9-lactone
- (5Z,13E,15S)-9α,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic acid 1,15-lactone
- (5Z,13E,15S)-9α,15-Dihydroxy-16,16-dimethyl-11-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E,15S,17Z)-15-Hydroxy-9-oxoprosta-5,11,13,17-tetraen-1-oic acid
- (5Z,8β,13E,15S)-15-Hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid
- Methyl (5Z,13E,8R,9S,11R,12S,15S)-11,15-Bis(tert-butyldimethylsiloxy)-9-(methylamino)-8-(phenylsulfonyl)-5,13-prostadienoate
- Methyl (5Z,13E,8R,11R,12S,15S)-11,15-Bis(tert-butyldimethylsiloxy)-9-(anti-oximino)-8-(phenylsulfonyl)-5,13-prostadienoate
- (5Z,13E,15S)-15-[[(tert-Butyl)dimethylsilyl]oxy]-9-oxo-5,8(12),13-prostatrien-1-oic acid methyl ester